Product correctly added to cart.

discount label
GLPG-0492
View 3D

Biosynth logo

GLPG-0492

CAS: 1215085-92-9

Ref. 3D-QYB08592

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Wednesday 12 Feb 2025

Product Information

Name:
GLPG-0492
Description:

GLPG-0492 is a drug that inhibits the activity of the gene product, which is responsible for the production of hair. This drug binds to and inhibits the function of a receptor on the surface of cells. GLPG-0492 has been shown to have an effect on alopecia areata, polycystic ovarian syndrome, and cancer. The molecule does not bind to any other receptors, and therefore does not have any effects on other tissues. GLPG-0492 has been shown to be safe in vitro and in vivo, with no adverse effects observed when tested in human liver cells or gastrocnemius muscle cells. It also has good pharmacokinetic properties that make it suitable for oral administration. GLPG-0492 was designed using molecular modeling software based on data from urine samples taken from patients with alopecia areata and polycystic ovarian syndrome.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
389.33 g/mol
Formula:
C19H14F3N3O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-QYB08592 GLPG-0492

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".